Providence St. Joseph Health

Providence St. Joseph Health Digital Commons
Articles, Abstracts, and Reports
6-9-2020

Discrimination of benign from malignant breast lesions in dense
breasts with model-based analysis of regions-of-interest using
directional diffusion-weighted images.
Alan I Penn
Milica Medved
Vandana Dialani
Etta D Pisano
Elodia B Cole

See next page for additional authors

Follow this and additional works at: https://digitalcommons.psjhealth.org/publications
Part of the Oncology Commons, and the Radiology Commons

Recommended Citation
Penn, Alan I; Medved, Milica; Dialani, Vandana; Pisano, Etta D; Cole, Elodia B; Brousseau, David; Karczmar,
Gregory S; Gao, Guimin; Reich, Barry D; and Abe, Hiroyuki, "Discrimination of benign from malignant breast
lesions in dense breasts with model-based analysis of regions-of-interest using directional diffusionweighted images." (2020). Articles, Abstracts, and Reports. 3245.
https://digitalcommons.psjhealth.org/publications/3245

This Article is brought to you for free and open access by Providence St. Joseph Health Digital Commons. It has
been accepted for inclusion in Articles, Abstracts, and Reports by an authorized administrator of Providence St.
Joseph Health Digital Commons. For more information, please contact digitalcommons@providence.org.

Authors
Alan I Penn, Milica Medved, Vandana Dialani, Etta D Pisano, Elodia B Cole, David Brousseau, Gregory S
Karczmar, Guimin Gao, Barry D Reich, and Hiroyuki Abe

This article is available at Providence St. Joseph Health Digital Commons: https://digitalcommons.psjhealth.org/
publications/3245

Penn et al. BMC Medical Imaging
(2020) 20:61
https://doi.org/10.1186/s12880-020-00458-3

RESEARCH ARTICLE

Open Access

Discrimination of benign from malignant
breast lesions in dense breasts with modelbased analysis of regions-of-interest using
directional diffusion-weighted images
Alan I. Penn1* , Milica Medved2, Vandana Dialani3, Etta D. Pisano3,4, Elodia B. Cole4, David Brousseau5,
Gregory S. Karczmar2, Guimin Gao6, Barry D. Reich1 and Hiroyuki Abe2

Abstract
Background: There is an increasing interest in non-contrast-enhanced magnetic resonance imaging (MRI) for
detecting and evaluating breast lesions. We present a methodology utilizing lesion core and periphery region of
interest (ROI) features derived from directional diffusion-weighted imaging (DWI) data to evaluate performance in
discriminating benign from malignant lesions in dense breasts.
Methods: We accrued 55 dense-breast cases with 69 lesions (31 benign; 38 cancer) at a single institution in a
prospective study; cases with ROIs exceeding 7.50 cm2 were excluded, resulting in analysis of 50 cases with 63
lesions (29 benign, 34 cancers). Spin-echo echo-planar imaging DWI was acquired at 1.5 T and 3 T. Data from three
diffusion encoding gradient directions were exported and processed independently. Lesion ROIs were hand-drawn
on DWI images by two radiologists. A region growing algorithm generated 3D lesion models on augmented
apparent-diffusion coefficient (ADC) maps and defined lesion core and lesion periphery sub-ROIs. A lesion-core and
a lesion-periphery feature were defined and combined into an overall classifier whose performance was compared
to that of mean ADC using receiver operating characteristic (ROC) analysis. Inter-observer variability in ROI definition
was measured using Dice Similarity Coefficient (DSC).
Results: The region-growing algorithm for 3D lesion model generation improved inter-observer variability over
hand drawn ROIs (DSC: 0.66 vs 0.56 (p < 0.001) with substantial agreement (DSC > 0.8) in 46% vs 13% of cases,
respectively (p < 0.001)). The overall classifier improved discrimination over mean ADC, (ROC- area under the curve
(AUC): 0.85 vs 0.75 and 0.83 vs 0.74 respectively for the two readers).
Conclusions: A classifier generated from directional DWI information using lesion core and lesion periphery
information separately can improve lesion discrimination in dense breasts over mean ADC and should be
considered for inclusion in computer-aided diagnosis algorithms. Our model-based ROIs could facilitate
standardization of breast MRI computer-aided diagnostics (CADx).
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Background
There is an increasing interest in the use of non-enhanced
breast diffusion-weighted imaging (DWI). This is due in
part to concern of harm from gadolinium, the enhancing
agent used with dynamic-contrast-enhanced MRI
(DCEMRI) [1, 2]. A common lesion classifier is the mean
value of apparent-diffusion coefficient (ADC) calculated
over a lesion region-of-interest (ROI). However, lesion
ROIs can include cysts and/or areas of necrosis, or suffer
from volume-averaging at boundaries – all of which can degrade the effectiveness of mean ADC as a discriminator.
Several studies have investigated methods of extracting and
evaluating only the relevant portions, or sub-ROIs, of the
original full-lesion ROI. They have concluded that ROI
placement significantly influences reported ADC values in
breast tumors and that smaller ROIs are frequently associated with improved discrimination [3–5].
Methods of defining sub-ROIs have varied widely among
investigators. For example, including manually avoiding
areas identified on pre-contrast T1- or T2-weighted images
[6, 7], using very small (3–4 pixel) subregions with low intensity signals [4], and covering the full-lesion ROI with circular sub-ROIs of fixed size and selecting the sub-ROI with
lowest ADC value [8] have been tested. Differences in subROI selection methodologies and imaging protocols have
led to reported results that are hard to compare across
studies [9, 10]. The method of defining the ROI affects
lesion-averaged ADC values, since drawing an ROI by hand
or placing geometric shapes over or within the lesion can
introduce bias by including background pixels and/or excluding lesion pixels at the boundary [8, 11–14]. Previous
studies showed that ADC values for malignant tumors depend upon how much peri-tumor tissue is included in the
evaluation. Specifically, ADC of the central part of a malignant lesion was significantly lower than ADC of the whole
lesion, while there was no significant difference for benign
lesions [7, 15]. Partridge et al. and Zeilinger et al. noted limitations of hand-drawn ROIs, including ROI reproducibility
and accuracy, and the difficulty in propagating ROIs from
DCEMRI to DWI images [14, 16].
We present a model-based approach that introduces
three methodological novelties for DWI data acquisition
and post-processing. First, we obtain and utilize separately
the information from the three diffusion-encoding gradient
datasets. Second, we introduce a region-growing algorithm
for generating 3D, topologically connected lesion volumeof-interest (VOI) models from which 2D ROIs are derived.
Finally, rather than analyzing the lesion as a single ROI,
we define lesion-core and periphery sub-ROI (peri-lesion) and derive separate features for the two. This was
motivated by earlier studies showing that analysis of
peri-lesion tissue can provide a discriminatory feature
(morphological blooming) in DCEMRI [17] and in
ADC analysis [15].
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The purpose of this work is to present a new approach
that introduces the three methodological improvements
and to demonstrate that it leads to enhanced diagnostic
performance over using the mean ADC of the lesion
ROI as a classifier of malignant vs benign lesions. Only
patients with dense breasts are included in the study, as
this is the population with the worst diagnostic performance on mammography and thus with the greatest need
for improved imaging techniques.

Methods
Patient recruitment and imaging protocol

The study was performed under an IRB-approved protocol, with informed consent obtained from all subjects. Patients with breast lesions found on mammographic and/or
sonographic exams were recruited prospectively before
breast biopsy was performed. Subjects who had undergone
prior treatment were not accrued, as that could distort diffusion signals. Fifty-five patients with 69 lesions (38 malignant; 31 benign) were imaged between Jan. 1, 2015 and
Nov 15, 2016 using 1.5 T and 3.0 T MR systems. Lesions,
as annotated by Radiologist 1 who had access to all imaging and clinical data, were categorized by maximum inplane area as follows: small-medium (55 lesions: 0.14
cm2–6.74 cm2) and large (6 lesions: 8.63 cm2–49.30 cm2).
The data set contained no lesions with sizes between
6.74 cm2 and 8.63 cm2, and cases with ROIs larger than
that gap were excluded. The diameter of tumors having
sizes within the range of the gap is approximately 3 cm.
Clinical studies suggest that there is a low risk of local recurrence with breast conservation surgery in invasive
breast cancers that are less than 3 cm in diameter [18].
Thus, choosing cancers less than 3 cm is clinically meaningful and minimized the size bias of discriminating features. The threshold 7.50 cm2 was nominally used to
represent the gap 6.74 cm2 to 8.63 cm2.
No lesions were excluded because of imaging problems
or patient motion. The study set included 49 masses (26
cancer; 23 benign). 12 non-mass enhancements (NME) (8
cancer; 4 benign) and two benign lesions that were identified on mammography as calcifications 1 and architectural
distortion 1 but negative on DCEMRI. Twelve lesions
were found in extremely dense breasts and 51 in heterogeneously dense breasts. All lesions underwent imageguided biopsies following MR imaging.
The subjects underwent DWI, non-fat suppressed T2weighted imaging, and DCEMRI using dedicated 16channel Mammotrack phased array breast coils (Philips
Healthcare, Best, Netherlands), at a 1.5 T Achieva (Philips
Healthcare, Best, Netherlands; 1 benign; 3 malignant lesions) and a 3 T Achieva (Philips Healthcare, Best,
Netherlands; 30 benign; 35 malignant lesions). Diffusion
weighted images were acquired prior to the administration
of gadolinium-based contrast agent and the acquisition of
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DCEMRI. Spin-echo echo-planar imaging (SE-EPI) was
used to generate diffusion weighted images and corresponding ADC maps in the axial plane, with imaging parameters shown in Table 1. DWI data were acquired,
retained, and analyzed individually for each of the three diffusion gradient encoding directions.
Image analysis

Images were analyzed by two fellowship-trained breast radiologists with over 10 years of experience (HA, VD) who
read MRI as part of their clinical practice. Radiologist 1,
who was familiar with clinical results and had access to
mammographic, sonographic and DCEMRI images in
addition to DWI images, selected one of the ADC, b = 0 s/
mm2, b = 50 s/mm2 or b = 800 s/mm2 series for lesion delineation based on the reader’s assessment of lesion visibility. Radiologist 1 then selected the set of axial slices
containing the lesion that would be annotated and drew lesion ROIs on each of the selected axial slices. The slice with
the largest ROI was designated the “index slice.” Annotations of Radiologist 1 were drawn on interpolated images
(512 × 534–1274 × 994 pixels) using the 1680 × 1050 HP
Compaq LA2205wg monitor (Hewlett-Packard, Palo Alto,
CA) which recorded, for each annotated slice, the size of
the marked ROI in cm2 (see, e.g., Fig. 1a). The annotated
images were then down-sampled to the original size of the
DICOM images (240 × 240–336 × 336 pixels). Pixels on the
down-sampled images have signal contribution from multiple interpolated pixels and were included in the final ROI
when a given percentage of contributing pixels had been
included in the hand-drawn ROI. This percentage was
selected such that the final ROI size in cm2 was the closest
to that on the interpolated image, for each case.
To simulate reading conditions of a non-contrast MRI
exam, Radiologist 2 was presented with mammographic,
sonographic, and DWI images but was blinded to clinical report results and DCEMRI images. Radiologist 2
was also presented with arrows pointing to the approximate location of the lesion on b = 0 and 800 s/mm2 images and with ADC maps of the index slice. Radiologist
2 used these images to assess the location and extent of
the lesion, selected the index DW image to be annotated
Table 1 Imaging parameters for the SE-EPI DWI sequence
TR [ms]

Philips Achieva 1.5 T

Philips Achieva 3.0 T

16,860–16,960

10,546–13,863

TE [ms]

80.1

63.9–67.5

Field-of-view [mm2]

300 × 300–330 × 330

300 × 300–390 × 390

In-plane resolution [mm]

1.15–1.25

1.04–1.25

Slice thickness [mm]

2.5

2.5

Number of slices

80

65–80

b values [s/mm2]

0, 800

0, 800
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independently from Reader 1 selection, and hand drew
the lesion ROI on this index slice using Mi-Forms Designer v.11 (Mi-Corporation, Durham, NC) on a Lenovo
Thinkpad X230 Tablet PC. Radiologist 2 annotated images interpolated to a fixed-size template of 340 × 340
pixels and the annotated images were then downsampled to the original size of the DICOM images.
Pixels in the down-sampled images were included in the
ROI if at least 50% of contributing pixels were in the
ROI on the 340 × 340 image.
Directional ADC maps were constructed for each diffusion gradient encoding dataset (Eq. 1):

ADCd ¼ ð1=b800 Þ ln S0 =Sd;800
ð1Þ
where S0 is the signal intensity in DW image obtained at
b = 0 s/mm2 and Sd,800 is the signal intensity in DW
image obtained for the given diffusion encoding gradient
direction (d = r, p, or s for readout, phase encoding, and
slice encoding direction, respectively) and b = 800 s/
mm2. An augmented directional ADC map (auADCd)
was constructed for each of the three directional ADCd
maps by multiplying the pixel intensity on the directional ADCd map by the corresponding pixel intensity of
the S0 image (Eq. 2).
auADCd ¼ S0 ADCd

¼ S0 ð1=b800 Þ ln S0 =Sd;800

ð2Þ

S0 is a non-directional, T2-weighted image with increased lesion conspicuity that is low-resolution but with
spatial distortion that matches that of higher b-value
DW images and ADC maps. Using augmented auADCd
maps was previously found to perform well for lesion
ROI definition [19].
From ROIs drawn by Radiologists 1 and 2, independently, and for each direction separately, 3D VOI models
were computer-generated around the lesion by including
spatially connected voxels with auADCd signal higher
than a certain threshold. The 3D model VOIs crosssection in the index slice generally differed from the 2D
hand-drawn ROI, and the threshold was selected so that
the Jaccard similarity index between these was maximized [20]. The overlap of the hand-drawn ROI and the
3D VOI cross-section in the index slice defined the
“core-lesion sub-ROI”, while the remainder of the 2D
hand-drawn ROI constituted the “peri-lesion sub-ROI”.
Thus, three direction-dependent sets of core- and perilesion sub-ROIs were defined for each reader, and quantitative differences between these directional sub-ROIs
were exploited for enhanced diagnostic purposes.
Figure 1 illustrates the index slice containing an invasive
lobular carcinoma (ILC) in a 57-year-old patient with heterogeneously dense breasts imaged at 3.0 T. Figure 1a
shows the original hand-drawn ROI from Radiologist 1 on
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Fig. 1 2D cross-section of the model 3D lesion VOI

a b = 800 s/mm2 image. Figure 1b shows the hand-drawn
ROI superimposed in red on the ADC map. Figure 1c
shows green pixels that represent the cross-section with
the 3D computer lesion model constructed from auADCr
values. The lesion model in Fig. 1c is topologically connected in 3D, but not in 2D, as shown. Green pixels that
lie within the hand-drawn ROI form the lesion-core; black
pixels that are within the hand-drawn ROI but are not in
the computer model form the peri-lesion.
ROC analysis

The ROC analysis was targeted for a binary classification,
where positive samples were malignant lesions and negative samples were benign lesions. Sensitivity was defined
as the ratio of the number of true positives over the sum
of the numbers of true positives and false negatives. Specificity was defined as the ratio of the number of true negatives over the sum of the numbers of true negatives and
false positives. Sensitivity was evaluated at specificity equal
to 90% on the ROC curves [21]. Within core- and perilesion sub-ROIs, a threshold of ADC = 1.37 mm2/s was selected to separate “benign-like” (ADC ≥ 1.37 mm2/s) from
“cancer-like” voxels (ADC < 1.37 mm2/s), based on a previously published study [19]. The quantitative feature defined for lesion-core ROIs was the standard deviation of
area covered by cancer-like voxels (SDAC) over the three
directions. Thus, SDAC directly quantifies differences between directional DWI datasets, and higher SDAC values
indicate higher probability of cancer. If the mean area covered by cancer-like pixels was < 6.67 mm2, (i.e., total area
for three directions < 20 mm2) the cancer-like pixels were
assumed to be spurious and SDAC was forced to 0, indicating benignity. The quantitative feature defined for perilesion ROIs was the area covered by cancer-like pixels
minus the area covered by benign-like pixels (ACMB) over
all three directions, with negative values permitted. Higher
ACMB values indicated higher probability of cancer.
SDAC was combined with ACMB into a single ROC
model-based classifier (MBC), using logistic regression
with 5-fold cross validation. The baseline discrimination
classifier for each reader was the mean ADC value over

the hand-drawn ROIs. Mass lesions and lesions smaller
than 1 cm2 were also independently analyzed.
Statistical analysis

Differences between benign and malignant ROI sizes
were evaluated using a 2-sided t-test, with significance
level 0.05. Diagnostic performance of mean ADC, SDAC,
ACMB, and MBC was evaluated using pROC and
cvAUC packages in R (http://cran.us.r-project.org) [21].
Logistic regression with repeated stratified 5-fold crossvalidation was used. Binormal ROC curves were constructed using cross-validated model parameters..
The Dice Similarity Coefficient (DCS) was used to
evaluate inter-observer variability between ROIs resulting
from Radiologist 1 and Radiologist 2 readings. The DCS
values for each lesion averaged over the three directional
algorithm-generated lesion-core sub-ROIs were compared
to the DSC values for hand-drawn lesion ROIs, using the
Wilcoxon signed-rank test. The McNemar test was used
to compare percentages of cases with DSC greater than
0.8 (indicating substantial agreement) [22, 23].

Results
Figure 2 shows the hand-drawn lesion ROIs (light blue,
a and b) and lesion-core pixel sets (c and d) obtained
from phase directional ADCp map as defined by Radiologist 1 (left) and Radiologist 2 (right), in a 63-year-old
patient with heterogeneously dense breasts with an invasive ductal carcinoma (IDC) lesion. The red and blue
pixels in Fig. 2c-d mark the lesion core with red indicating cancer-like (ADC < 1.37) and blue indicating benignlike (ADC ≥ 1.37) voxels.
The mean sizes and standard deviations of study lesions,
as recorded from annotations by Radiologist 1, were
154 ± 165 mm2 (min, median, max: 16, 80, 673 mm2) and
179 ± 142 mm2 (min, median, max: 14, 121, 463 mm2) for
benign and malignant lesions, respectively (p = 0.52). The
mean DSC values over study cases were 0.56 for handdrawn ROIs (0.57 and 0.55 in cancer and benign cases, respectively) vs 0.66 for computer-generated lesion-core
sub-ROIs (0.63 and 0.70 in cancers and benign cases,
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Fig. 2 Definition of lesion core and lesion periphery sub-ROIs

respectively) (p < 0.001). For hand-drawn ROIs, 12.7% of
cases had mean DSC > 0.8 (11.8 and 13.8% in cancer and
benign cases, respectively), vs 46.0% in algorithmgenerated lesion core sub-ROIs (38.2 and 55.2% in cancer
and benign cases, respectively). This difference was statistically significant (p < 0.001).
Figure 3 shows the corresponding baseline (mean ADC)
and overall model-based classifier binormal ROC curves
for Radiologist 1 and Radiologist 2. At specificity of 90%
(3 FP; 26 TN), sensitivity for Radiologist 1 improved from
27 to 64% and sensitivity for Radiologist 2 improved from
19 to 49% for model-based classifier over baseline.
Table 2 shows ROC AUC values for baseline discrimination, ACMB, SDAC, and the overall model-based
classifier for the two radiologists. Table 3 shows ROC
AUC values for baseline discrimination, ACMB, and
SDAC for small lesions (areas < 1 cm2; n = 29) as marked

by Radiologist 1. Excluding from analysis the 4 lesions
obtained at 1.5 T field strength did not materially change
the AUC values. For Radiologist 1: AUCs for 3.0 T cases
only were 0.755 and 0.860, for mean ADC and MBC, respectively, compared to AUC values for all cases of
0.748 and 0.850. For Radiologist 2: 3.0 T cases had AUC
values of 0.740 and 0.843 compared to values for all
cases of 0.743 and 0.829.
Figure 4 shows the AUC values computed for lesions
as marked by Radiologist 1 for lesions with areas less
than 1 cm2 (n = 29) and for all lesions (n = 63).

Discussion
We have tested the performance of a model-based classifier for characterizing breast lesions, introducing three
new techniques. First, we used a region-growing algorithm for generating topologically connected 3D lesion

Fig. 3 Binormal ROC curves for baseline and model-based classifier for the two readers
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Table 2 ROC analysis results
Radiologist

Feature (No cases)

Radiologist 1

baseline (63)

0.748

ACMB (63)

0.830

SDAC (63)

0.846

MBC (63)

0.850

Masses (49): baseline / MBC

0.789/0.930

baseline (63)

0.743

ACMB

0.831

SDAC

0.775

MBC (63)

0.829

Masses (49): baseline / MBC

0.760/0.874

Radiologist 2

AUC

baseline = mean ADC of hand-drawn ROI.
MBC = model-based classier

VOI models from which 2D lesion ROIs are derived. This
algorithm operates on augmented directional ADC maps,
where values of the directional ADC map are multiplied
with corresponding values of the b = 0 s/mm2 DW image.
Second, we retained and utilized the information from the
three diffusion-encoding direction datasets separately,
thus defining three different model-based sets of 3D VOIs
and 2D ROIs. Finally, we divided the lesion ROI into
lesion-core and peri-lesion sub-ROIs and derived distinct
features for each which are combined into the overall
model-based classifier. The improvements over baseline
ROC AUC values validate our approach.
Our results indicate that inter-observer variability could
be improved if lesion-core ROIs are standardized by
employing algorithm-based definition. Improved interobserver variability is important for both the clinical application of breast lesion discrimination and for development
of CADx systems for breast cancer detection and diagnostics. We observed an increase in the percentage of cases
with substantial agreement for lesion-core sub-ROIs. This
demonstrates the benefit of computer-based ROI selection
and potential for standardization of ADC measurement
between observers and, potentially, institutions and
manufacturers.
Table 3 ROC analysis results for lesions smaller than 1 cm2
Radiologist
Radiologist 1

Radiologist 2

Feature (29 cases)

AUC

baseline

0.670

ACMB

0.694

SDAC

0.782

MBC

0.747

baseline

0.707

ACMB

0.760

SDAC

0.667

MBC

0.726

baseline = mean ADC of hand-drawn ROI.

For both radiologists, our model-based classifier resulted in improvement in AUC over that obtained
from mean ADC. Improvement in AUC on small lesions was found for both radiologists using selftraining on their respective data sets; these results
suggest that it may be possible to improve discrimination of small lesions using the methods introduced
here, but a study with a larger set of small lesions is
required to validate that hypothesis. For lesions with
areas less than 1 cm2 in the index slice, the mean
ADC performed especially poorly and for Radiologist
1, SDAC – the lesion-core feature derived from differences in directional DW images – was responsible
for most of the improvement in AUC. Using only
three gradient directions, rather than a more timeintensive DTI sequence, preferentially labels as anisotropic the lesions that have a suitable orientation relative to the directions of the gradients. However, our
results demonstrate that even the limited anisotropy
information derived from DWI is helpful in improving diagnostic accuracy. This is most strikingly true
for small lesions, where the discrimination task is especially challenging. As the imaging time is not increased, this is a penalty-free method for improving
diagnostic performance.
Radiologist 1 defined hand-drawn lesion ROIs with access to all the clinical and radiological information,
which is the typical scenario for evaluation of suspicious
findings. Radiologist 2 drew lesion ROIs without access
to DCEMRI information. Importantly, MR imaging
was performed prior to lesion biopsy. Thus, our results are relevant to and could help improve accuracy
of either DCEMRI-based diagnostic or screening MRI
exams (Radiologist 1 analysis), or of non-contrastenhanced screening exams (Radiologist 2 analysis).
There are several limitations to this study. First, the
two Radiologists drew ROIs with different prior information, which could introduce variability. However, even
with these differences we have observed improved interreader agreement in lesion core ROIs. This indicates that
our method is more robust to variations in methodology
than using simple hand-drawn ROIs. Second, while this
prospective study was designed to include and analyze
all non-excluded cases, most of the cases (59/63) were
imaged on 3.0 T systems. In our sample however,
restricting the analysis to cases imaged at 3.0 T resulted
in minimal differences in AUC values without materially
impacting the results. Third, we used a fixed ADC cutoff
for SDAC and ACMB definitions, based on earlier results, and it is possible that a more optimal cutoff value
would yield improved discrimination. Finally, this study
was restricted to women with dense breasts and it remains to be seen how these results translate to the general population.
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Fig. 4 AUC values for baseline, ACMB, SDAC, and MBC, by lesion size

Conclusions
The combination of (a) independent evaluation of DWI
directional signals, (b) model-based VOIs, and (c) features
derived separately from lesion-core and peri-lesion ROIs
defined on augmented ADC maps could improve discrimination of benign from malignant breast lesions in women
with dense breasts. Inter-observer variability among
readers could be reduced by modeling lesions as 3D, topologically connected VOIs from which 2D ROIs are derived. The use of limited anisotropic information derived
from directional DWI datasets improves diagnostic accuracy without an acquisition time penalty. The methods introduced here could potentially increase the diagnostic
accuracy of both DCEMRI-based and non-contrast
screening breast MRI exams.
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